Singapore, Dec. 1 -- Zuellig Pharma, a leading healthcare solutions company in Asia, has announced the grand opening of its new state-of-the-art Clinical Trial Support (CTS) Innovation Centre in South Korea.
Strategically located near the Gyeongbu Expressway in Gyeonggi-do province, the new 3,800-square-meter facility is set to redefine standards in clinical trial logistics through automation, digitalisation, and stringent Good Practice (GxP) compliance. It is designed to enhance operational efficiency, scalability, and reliability across diverse therapeutic areas.
The facility is equipped with advanced capabilities that set new standards for clinical trial logistics. It features a fully automated order fulfillment system that enhances ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.